B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GLUL

MOLECULAR TARGET

glutamate-ammonia ligase

UniProt: P15104NCBI Gene: 27521 compounds

GLUL (glutamate-ammonia ligase) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GLUL

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Prednisolone0.691

About GLUL as a Drug Target

GLUL (glutamate-ammonia ligase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented GLUL interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GLUL inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.